Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

Author:

Gras-Martín Laura123ORCID,Plaza-Diaz Adrián12,Zarate-Tamames Borja12,Vera-Artazcoz Paula234ORCID,Torres Olga H.235ORCID,Bastida Carla67ORCID,Soy Dolors67ORCID,Ruiz-Ramos Jesús123ORCID

Affiliation:

1. Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain

2. Institut de Recerca Sant Pau (IR SANT PAU), Sat Quintí 77-79, 08041 Barcelona, Spain

3. Department of Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain

4. Intensive Care Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain

5. Geriatric Unit, Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025 Barcelona, Spain

6. Pharmacy Department, Division of Medicines, Hospital Clinic of Barcelona, Villarroel 170, 08036 Barcelona, Spain

7. Department of Pharmacology, Toxicology and Therapeutical Chemistry, Faculty of Pharmacy, Universitat de Barcelona, Campus Diagonal, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain

Abstract

(1) Background: Knowledge about the behavior of antibiotics in critically ill patients has been increasing in recent years. Some studies have concluded that a high percentage may be outside the therapeutic range. The most likely cause of this is the pharmacokinetic variability of critically ill patients, but it is not clear which factors have the greatest impact. The aim of this systematic review is to identify risk factors among critically ill patients that may exhibit significant pharmacokinetic alterations, compromising treatment efficacy and safety. (2) Methods: The search included the PubMed, Web of Science, and Embase databases. (3) Results: We identified 246 observational studies and ten clinical trials. The most studied risk factors in the literature were renal function, weight, age, sex, and renal replacement therapy. Risk factors with the greatest impact included renal function, weight, renal replacement therapy, age, protein or albumin levels, and APACHE or SAPS scores. (4) Conclusions: The review allows us to identify which critically ill patients are at a higher risk of not reaching therapeutic targets and helps us to recognize the extensive number of risk factors that have been studied, guiding their inclusion in future studies. It is essential to continue researching, especially in real clinical practice and with clinical outcomes.

Publisher

MDPI AG

Reference309 articles.

1. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021;Evans;Intensive Care Med.,2021

2. Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development;Lipman;Semin. Respir. Crit. Care Med.,2015

3. Therapeutic drug monitoring of β-lactam antibiotics in the ICU;Dhaese;Expert Rev. Anti-infective Ther.,2020

4. Blasco, A.C., Alfaro, L.A., Reinoso, J.C., Mestre, M.J.G., and Rodríguez-Gascón, A. (2015). Análisis Farmacocinético-Farmacodinámico en Microbiología: Herramienta para Evaluar el Tratamiento Antimicrobiano Enfermedades Infecciosas y Microbiologia Clinica, Elsevier Doyma.

5. Rizk, M.L., Bhavnani, S.M., Drusano, G., Dane, A., Eakin, A.E., Guina, T., Jang, S.H., Tomayko, J.F., Wang, J., and Zhuang, L. (2019). Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents. Antimicrob. Agents Chemother., 63.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3